The Sioux Technologies-backed solar-powered vehicle developer has secured new funding as it prepares to complete the first deliveries of its cars later this year.

China Merchants Group led a series C round for the antibody drug developer that was also backed by fellow corporates Tigermed and Dawn.

Boehringer Ingelheim Venture Fund returned to reinvest in the regenerative therapy developer after backing its series A round two years ago.

The regenerative therapy developer is based on research at University of Torino and has raised capital from returning backer V-Bio Ventures.

Coinbase, American Express and CMT Group contributed to the cryptocurrency trading platform operator’s first round since it emerged from stealth last year.

Tencent co-led the real estate portal operator’s series C-plus round, which also featured Eight Roads Ventures, Sequoia Capital China and Source Code Capital.

Sony and Pksha Technology helped the vertical strawberry farm operator raise cash that will go to increasing production and widening its product range.

Argo Blockchain will retain a 25% stake in the crypto investor and technology incubator after leading its latest round.

The Novel Group and CAA-backed wholesale marketplace platform developer has taken in funding from investors including Brighton Park Capital and Imaginary Ventures.

Sany Group and Fosun contributed to a $61.4m round for the third-party drug development services provider, which counts Jilin Aodong Medicine as an earlier backer.